Correction to Spotlight, February 2014 - American Chemical Society

Feb 14, 2014 - sulforaphane should appear under the subheading Exemestane. Facilitates Multifaceted Chemoprevention instead of under. Disruption of ...
0 downloads 0 Views 101KB Size
Addition/Correction pubs.acs.org/crt

Correction to Spotlight, February 2014 Heidi Dahlmann* Chem. Res. Toxicol. 2014, 27 (2), 157−158. DOI: 10.1021/tx500025s n the February 2014 edition of Spotlight, the figures should appear in the following order: the drawing of exemstane and sulforaphane should appear under the subheading Exemestane Facilitates Multifaceted Chemoprevention instead of under Disruption of Glutathione Metabolism Kills Leukemia Cells. The drawing of parthenolide and piperlongumine should appear under Disruption of Glutathione Metabolism Kills Leukemia Cells instead of under Intestinal Glucuronidation Defends against CPT-11 Side Effects, and the drawing depicting CPT-11 biotransformation should appear under Intestinal Glucuronidation Defends against CPT-11 Side Effects instead of under Exemestane Facilitates Multifaceted Chemoprevention.

I

Published: February 14, 2014 © 2014 American Chemical Society

710

dx.doi.org/10.1021/tx500043a | Chem. Res. Toxicol. 2014, 27, 710−710